COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2078: Articles 20771-20780  | Next

Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
Touret, F., Driouich, J.-S., Cochin, M., Petit, P. R., Gilles, M., Barthelemy, K., Moureau, G., Malvy, D., Solas, C., de Lamballerie, X., Nougairede, A.
10.1101/2020.11.17.386904 — Posted: 2020-11-17
Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
Braun, K. M., Moreno, G. K., Halfmann, P. J., Baker, D. A., Boehm, E. C., Weiler, A. M., Haj, A. K., Hatta, M., Chiba, S., Maemura, T., Kawaoka, Y., Koelle, K., O'Connor, D., Friedrich, T.
10.1101/2020.11.16.384917 — Posted: 2020-11-17 Discussion: Onsite | Offsite
Mosaic RBD nanoparticles elicit neutralizing antibodies against SARS-CoV-2 and zoonotic coronaviruses
Bjorkman, P. J., Cohen, A. A., Gnanapragasam, P. N. P., Lee, Y. E., Ou, S., Kakutani, L. M., Keeffe, J. R., Barnes, C. O., Nussenzweig, M. C.
10.1101/2020.11.17.387092 — Posted: 2020-11-17
Simple Accurate Regression-Based Forecasting of Intensive Care Unit Admissions due to COVID-19 in Ontario, Canada
Fisman, D., Tuite, A.
10.1101/2020.11.16.20231399 — Posted: 2020-11-17
Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up
Nersesjan, V., Amiri, M., Lebech, A.-M., Roed, C., Mens, H., Russell, L., Fonsmark, L., Berntsen, M., Sigurdsson, S. T., Carlsen, J., Langkilde, A., Martens, P., Lund, E. L., Hansen, K., Jespersen, B., Folke, M. N., Meden, P., Hejl, A.-M., Warmberg, C., Benros, M., Kondziella, D.
10.1101/2020.11.15.20231001 — Posted: 2020-11-17
Effect of Vitamin D3 Supplementation vs Placebo on Hospital Length of Stay in Patients with Severe COVID-19: A Multicenter, Double-blind, Randomized Controlled Trial.
Murai, I. H., Fernandes, A. L., Sales, L. P., Pinto, A. J., Goessler, K. F., Duran, C. S. C., Silva, C. B. R., Franco, A. S., Macedo, M. B., Dalmolin, H. H. H., Baggio, J., Balbi, G. G. M., Reis, B. Z., Antonangelo, L., Caparbo, V. F., Gualano, B., Pereira, R. M. R.
10.1101/2020.11.16.20232397 — Posted: 2020-11-17 Discussion: Onsite
The impact of the coronavirus disease 2019 (COVID-19) outbreak on hospital admissions for alcohol-related liver disease and pancreatitis: a time-series analysis
Itoshima, H., Shin, J.-h., Takada, D., Morishita, T., Kunisawa, S., Imanaka, Y.
10.1101/2020.11.16.20232181 — Posted: 2020-11-17
Nasopharyngeal Panbio COVID-19 antigen performed at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age
Masia, M., Fernandez-Gonzalez, M., Sanchez, M., Carvajal, M., Garcia, J. A., Gonzalo, N., Ortiz de la Tabla, V., Agullo, V., Candela, I., Guijarro, J., Gutierrez, J. A., De Gregorio, C., Gutierrez, F.
10.1101/2020.11.16.20230003 — Posted: 2020-11-17
The total number and mass of SARS-CoV-2 virions in an infected person
Sender, R., Bar-On, Y. M., Flamholz, A., Gleizer, S., Bernsthein, B., Phillips, R., Milo, R.
10.1101/2020.11.16.20232009 — Posted: 2020-11-17
Deconditioning in people living with dementia during the COVID-19 pandemic: findings from the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) process evaluation
Di Lorito, C., Masud, T., Gladman, J., Godfrey, M., Dunlop, M., Harwood, R. H.
10.1101/2020.11.16.20231100 — Posted: 2020-11-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).